• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用单克隆抗体对流感病毒神经氨酸酶(N2)进行抗原和生物学特性分析。

Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.

作者信息

Webster R G, Brown L E, Laver W G

出版信息

Virology. 1984 May;135(1):30-42. doi: 10.1016/0042-6822(84)90114-4.

DOI:10.1016/0042-6822(84)90114-4
PMID:6203218
Abstract

Competitive radioimmunoassays using monoclonal antibodies established that the neuraminidase of A/RI/5+/57 (H2N2) influenza can be divided into four overlapping antigenic regions. Antigenic regions 1 and 4 are sufficiently far apart so that there was no competition between antibodies for these sites. Region 1 is conserved in neuraminidases from N2 viruses over a 10-year period, while the other regions changed antigenically during this time. The antibodies belonging to groups 2 and 3 completely inhibited catalytic activity on fetuin substrate, whereas antibodies in groups 1 and 4 inhibited weakly or not at all. Antigenic region 2 can be further divided into four overlapping areas (2a, 2b, 2c, and 2d) based on the reactivity patterns of monoclonal antibodies with antigenic variants, chemically modified neuraminidase, and the ability of the antibodies to inhibit enzyme activity of different molecular weight substrates. Previous studies [R. G. Webster, V. S. Hinshaw , and W. G. Laver (1982) Virology 117, 93-104; D. C. Jackson and R. G. Webster (1982) Virology 123, 69-77] characterized only region 2 of the neuraminidase molecule. Each of the monoclonal antibodies inhibited virus release from MDCK cells when incorporated in an agar overlay, and some antibodies in each group inhibited hemagglutination by intact virus, but only antibodies in group 2 neutralized virus in embryonated eggs and permitted selection of antigenic variants. The results indicate that antibodies to some antigenic sites on the neuraminidase may inhibit virus release more efficiently than others, depending on their relation to the enzyme active center. None of the monoclonal antibodies inhibited the hemolytic activity of viruses possessing N2. Based on antigenic mapping and biological properties of the monoclonal antibodies, a topographical map of the neuraminidase can be constructed. It is proposed that antigenic regions 1 and 4 are spacially separated and, based on their failure to inhibit biological activity, may be located on the bottom surface of the molecule; region 3 may be on the top surface of the molecule but at some distance from the catalytic center. Antigenic region 2 probably encompasses most of the top surface of the molecule; region 2d being closest to the enzyme center, with subregions 2a and 2b adjacent to it on the top surface. Chemical treatment of the neuraminidase with trinitrobenzenesulfonic acid (TNBS) causes modification of the 2b region, confirming the antigenic mapping results.

摘要

利用单克隆抗体进行的竞争性放射免疫分析表明,A/RI/5+/57(H2N2)流感病毒的神经氨酸酶可分为四个重叠的抗原区域。抗原区域1和4相距足够远,以至于针对这些位点的抗体之间不存在竞争。区域1在10年期间N2病毒的神经氨酸酶中是保守的,而其他区域在此期间发生了抗原性变化。属于第2组和第3组的抗体完全抑制了对胎球蛋白底物的催化活性,而第1组和第4组的抗体抑制作用较弱或根本没有抑制作用。基于单克隆抗体与抗原变体、化学修饰的神经氨酸酶的反应模式以及抗体抑制不同分子量底物酶活性的能力,抗原区域2可进一步分为四个重叠区域(2a、2b、2c和2d)。先前的研究[R.G.韦伯斯特、V.S.欣肖和W.G.拉弗(1982年),《病毒学》117卷,93 - 104页;D.C.杰克逊和R.G.韦伯斯特(1982年),《病毒学》123卷,69 - 77页]仅对神经氨酸酶分子的区域2进行了表征。当掺入琼脂覆盖物中时,每种单克隆抗体都抑制了病毒从MDCK细胞的释放,并且每组中的一些抗体抑制了完整病毒的血凝作用,但只有第2组中的抗体在鸡胚中中和了病毒并允许选择抗原变体。结果表明,针对神经氨酸酶上某些抗原位点的抗体可能比其他抗体更有效地抑制病毒释放,这取决于它们与酶活性中心的关系。没有一种单克隆抗体抑制具有N2的病毒的溶血活性。基于单克隆抗体的抗原图谱和生物学特性,可以构建神经氨酸酶的拓扑图。有人提出抗原区域1和4在空间上是分开的,并且基于它们未能抑制生物活性,可能位于分子的底面;区域3可能位于分子的顶面,但与催化中心有一定距离。抗原区域2可能涵盖分子的大部分顶面;区域2d最靠近酶中心,子区域2a和2b在顶面上与之相邻。用三硝基苯磺酸(TNBS)对神经氨酸酶进行化学处理会导致2b区域的修饰,证实了抗原图谱结果。

相似文献

1
Antigenic and biological characterization of influenza virus neuraminidase (N2) with monoclonal antibodies.用单克隆抗体对流感病毒神经氨酸酶(N2)进行抗原和生物学特性分析。
Virology. 1984 May;135(1):30-42. doi: 10.1016/0042-6822(84)90114-4.
2
Location of antigenic sites on the three-dimensional structure of the influenza N2 virus neuraminidase.流感N2病毒神经氨酸酶三维结构上抗原位点的定位
Virology. 1985 Sep;145(2):237-48. doi: 10.1016/0042-6822(85)90157-6.
3
Antigenic structure and variation in an influenza virus N9 neuraminidase.甲型流感病毒N9神经氨酸酶的抗原结构与变异
J Virol. 1987 Sep;61(9):2910-6. doi: 10.1128/JVI.61.9.2910-2916.1987.
4
Sequence of the neuraminidase gene of influenza virus A/Tokyo/3/67 and previously uncharacterized monoclonal variants.
Virology. 1984 May;135(1):257-65. doi: 10.1016/0042-6822(84)90135-1.
5
The neuraminidases of the virulent and avirulent A/Chicken/Pennsylvania/83 (H5N2) influenza A viruses: sequence and antigenic analyses.强毒力和无毒力的A/鸡/宾夕法尼亚/83(H5N2)甲型流感病毒的神经氨酸酶:序列和抗原分析
Virology. 1985 Nov;147(1):49-60. doi: 10.1016/0042-6822(85)90226-0.
6
Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.流感病毒N9神经氨酸酶单个表位的抗原变异机制。
J Virol. 1990 Dec;64(12):5797-803. doi: 10.1128/JVI.64.12.5797-5803.1990.
7
Analysis of influenza A virus neuraminidase using lectin test and monoclonal antibodies.利用凝集素试验和单克隆抗体对甲型流感病毒神经氨酸酶进行分析。
Acta Virol. 1986 Jul;30(4):281-8.
8
Catalytic properties of the A/H3N2 influenza neuraminidases: influence of antigenic variations.A/H3N2流感病毒神经氨酸酶的催化特性:抗原变异的影响
J Gen Virol. 1986 Mar;67 ( Pt 3):409-18. doi: 10.1099/0022-1317-67-3-409.
9
Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity.用单克隆抗体对H2流感病毒血凝素进行表征:受体特异性的影响
Virology. 1984 Oct 30;138(2):276-86. doi: 10.1016/0042-6822(84)90351-9.
10
The antigenic structure of the influenza B virus hemagglutinin: operational and topological mapping with monoclonal antibodies.乙型流感病毒血凝素的抗原结构:用单克隆抗体进行的功能和拓扑图谱分析
Virology. 1985 Jun;143(2):583-94. doi: 10.1016/0042-6822(85)90396-4.

引用本文的文献

1
A neuraminidase-based inactivated influenza virus vaccine significantly reduced virus replication and pathology following homologous challenge in swine.一种基于神经氨酸酶的灭活流感病毒疫苗在猪受到同源攻击后显著降低了病毒复制和病理变化。
Vaccine. 2025 Feb 6;46:126574. doi: 10.1016/j.vaccine.2024.126574. Epub 2024 Dec 7.
2
Epitopes in the HA and NA of H5 and H7 avian influenza viruses that are important for antigenic drift.H5 和 H7 禽流感病毒的 HA 和 NA 中的抗原漂移重要表位。
FEMS Microbiol Rev. 2024 May 8;48(3). doi: 10.1093/femsre/fuae014.
3
Swine influenza A virus infection dynamics and evolution in intensive pig production systems.
集约化养猪生产系统中甲型猪流感病毒的感染动态与进化
Virus Evol. 2024 Feb 27;10(1):veae017. doi: 10.1093/ve/veae017. eCollection 2024.
4
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase.保护性人源单克隆抗体针对流感病毒神经氨酸酶底面的保守弱点部位。
Immunity. 2024 Mar 12;57(3):574-586.e7. doi: 10.1016/j.immuni.2024.02.003. Epub 2024 Mar 1.
5
Sequential vaccinations with divergent H1N1 influenza virus strains induce multi-H1 clade neutralizing antibodies in swine.先后接种不同的 H1N1 流感病毒株可诱导猪体产生多 H1 分支中和抗体。
Nat Commun. 2023 Nov 27;14(1):7745. doi: 10.1038/s41467-023-43339-3.
6
Co-evolution of immunity and seasonal influenza viruses.免疫与季节性流感病毒的共同进化。
Nat Rev Microbiol. 2023 Dec;21(12):805-817. doi: 10.1038/s41579-023-00945-8. Epub 2023 Aug 2.
7
Antigenic characterization of influenza and SARS-CoV-2 viruses.流感病毒和 SARS-CoV-2 病毒的抗原特征。
Anal Bioanal Chem. 2022 Apr;414(9):2841-2881. doi: 10.1007/s00216-021-03806-6. Epub 2021 Dec 14.
8
Evolution and Antigenic Advancement of N2 Neuraminidase of Swine Influenza A Viruses Circulating in the United States following Two Separate Introductions from Human Seasonal Viruses.美国两种人季节性流感病毒传入后猪流感 A 病毒 N2 神经氨酸酶的进化和抗原性演变。
J Virol. 2021 Sep 27;95(20):e0063221. doi: 10.1128/JVI.00632-21. Epub 2021 Aug 11.
9
Infection Dynamics of Swine Influenza Virus in a Danish Pig Herd Reveals Recurrent Infections with Different Variants of the H1N2 Swine Influenza A Virus Subtype.丹麦猪群中猪流感病毒的感染动态揭示了 H1N2 猪流感 A 病毒亚型的不同变体的反复感染。
Viruses. 2020 Sep 10;12(9):1013. doi: 10.3390/v12091013.
10
Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice.H7N9 流感病毒神经氨酸酶特异性人源单克隆抗体抑制病毒释放并保护小鼠免受致死性流感感染。
Cell Host Microbe. 2019 Dec 11;26(6):715-728.e8. doi: 10.1016/j.chom.2019.10.003. Epub 2019 Nov 19.